ID   SYLM_HUMAN              Reviewed;         903 AA.
AC   Q15031;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   12-APR-2017, entry version 155.
DE   RecName: Full=Probable leucine--tRNA ligase, mitochondrial;
DE            EC=6.1.1.4;
DE   AltName: Full=Leucyl-tRNA synthetase;
DE            Short=LeuRS;
DE   Flags: Precursor;
GN   Name=LARS2; Synonyms=KIAA0028;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Bone marrow;
RX   PubMed=7584026; DOI=10.1093/dnares/1.1.27;
RA   Nomura N., Miyajima N., Sazuka T., Tanaka A., Kawarabayasi Y.,
RA   Sato S., Nagase T., Seki N., Ishikawa K., Tabata S.;
RT   "Prediction of the coding sequences of unidentified human genes. I.
RT   The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by
RT   analysis of randomly sampled cDNA clones from human immature myeloid
RT   cell line KG-1.";
RL   DNA Res. 1:27-35(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-236, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=20194621; DOI=10.1128/MCB.01614-09;
RA   Li R., Guan M.X.;
RT   "Human mitochondrial leucyl-tRNA synthetase corrects mitochondrial
RT   dysfunctions due to the tRNALeu(UUR) A3243G mutation, associated with
RT   mitochondrial encephalomyopathy, lactic acidosis, and stroke-like
RT   symptoms and diabetes.";
RL   Mol. Cell. Biol. 30:2147-2154(2010).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-711, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [8]
RP   VARIANTS PRLTS4 ASN-522 AND MET-629, AND CHARACTERIZATION OF VARIANTS
RP   PRLTS4 ASN-522 AND MET-629.
RX   PubMed=23541342; DOI=10.1016/j.ajhg.2013.03.007;
RA   Pierce S.B., Gersak K., Michaelson-Cohen R., Walsh T., Lee M.K.,
RA   Malach D., Klevit R.E., King M.C., Levy-Lahad E.;
RT   "Mutations in LARS2, encoding mitochondrial leucyl-tRNA synthetase,
RT   lead to premature ovarian failure and hearing loss in Perrault
RT   syndrome.";
RL   Am. J. Hum. Genet. 92:614-620(2013).
RN   [9]
RP   INVOLVEMENT IN HLASA, VARIANTS HLASA VAL-430 AND ASN-522, AND
RP   CHARACTERIZATION OF VARIANT HLASA VAL-430 AND ASN-522.
RX   PubMed=26537577; DOI=10.1007/8904_2015_515;
RA   Riley L.G., Rudinger-Thirion J., Schmitz-Abe K., Thorburn D.R.,
RA   Davis R.L., Teo J., Arbuckle S., Cooper S.T., Campagna D.R.,
RA   Frugier M., Markianos K., Sue C.M., Fleming M.D., Christodoulou J.;
RT   "LARS2 Variants Associated with Hydrops, Lactic Acidosis,
RT   Sideroblastic Anemia, and Multisystem Failure.";
RL   JIMD Rep. 28:49-57(2016).
CC   -!- CATALYTIC ACTIVITY: ATP + L-leucine + tRNA(Leu) = AMP +
CC       diphosphate + L-leucyl-tRNA(Leu).
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed, but highest expression
CC       in tissues with high metabolic rates, such as skeletal muscle,
CC       heart, and kidney. {ECO:0000269|PubMed:20194621}.
CC   -!- DISEASE: Perrault syndrome 4 (PRLTS4) [MIM:615300]: A sex-
CC       influenced disorder characterized by sensorineural deafness in
CC       both males and females, and ovarian dysgenesis in females.
CC       Affected females have primary amenorrhea, streak gonads, and
CC       infertility, whereas affected males show normal pubertal
CC       development and are fertile. {ECO:0000269|PubMed:23541342}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Hydrops, lactic acidosis, and sideroblastic anemia
CC       (HLASA) [MIM:617021]: A lethal, multisystem metabolic disorder
CC       characterized by severe lactic acidosis, hydrops, and
CC       sideroblastic anemia. Additional features include impaired cardiac
CC       function, disordered coagulation, pulmonary hypertension, and
CC       progressive renal disease. {ECO:0000269|PubMed:26537577}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA04877.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D21851; BAA04877.2; ALT_INIT; mRNA.
DR   EMBL; BC025989; AAH25989.1; -; mRNA.
DR   CCDS; CCDS2728.1; -.
DR   RefSeq; NP_056155.1; NM_015340.3.
DR   RefSeq; XP_005265063.1; XM_005265006.1.
DR   UniGene; Hs.526975; -.
DR   ProteinModelPortal; Q15031; -.
DR   SMR; Q15031; -.
DR   BioGrid; 116968; 22.
DR   STRING; 9606.ENSP00000265537; -.
DR   DrugBank; DB00149; L-Leucine.
DR   iPTMnet; Q15031; -.
DR   PhosphoSitePlus; Q15031; -.
DR   BioMuta; LARS2; -.
DR   DMDM; 2501029; -.
DR   EPD; Q15031; -.
DR   MaxQB; Q15031; -.
DR   PaxDb; Q15031; -.
DR   PeptideAtlas; Q15031; -.
DR   PRIDE; Q15031; -.
DR   DNASU; 23395; -.
DR   Ensembl; ENST00000265537; ENSP00000265537; ENSG00000011376.
DR   Ensembl; ENST00000415258; ENSP00000408576; ENSG00000011376.
DR   GeneID; 23395; -.
DR   KEGG; hsa:23395; -.
DR   UCSC; uc003cop.2; human.
DR   CTD; 23395; -.
DR   DisGeNET; 23395; -.
DR   GeneCards; LARS2; -.
DR   HGNC; HGNC:17095; LARS2.
DR   HPA; HPA035951; -.
DR   HPA; HPA045450; -.
DR   HPA; HPA066085; -.
DR   MalaCards; LARS2; -.
DR   MIM; 604544; gene.
DR   MIM; 615300; phenotype.
DR   MIM; 617021; phenotype.
DR   neXtProt; NX_Q15031; -.
DR   OpenTargets; ENSG00000011376; -.
DR   Orphanet; 2855; Perrault syndrome.
DR   PharmGKB; PA134982982; -.
DR   eggNOG; KOG0435; Eukaryota.
DR   eggNOG; COG0495; LUCA.
DR   GeneTree; ENSGT00390000015114; -.
DR   HOGENOM; HOG000200747; -.
DR   HOVERGEN; HBG017877; -.
DR   InParanoid; Q15031; -.
DR   KO; K01869; -.
DR   OMA; PRKLCAH; -.
DR   OrthoDB; EOG091G01P6; -.
DR   PhylomeDB; Q15031; -.
DR   TreeFam; TF105662; -.
DR   BRENDA; 6.1.1.4; 2681.
DR   Reactome; R-HSA-379726; Mitochondrial tRNA aminoacylation.
DR   SABIO-RK; Q15031; -.
DR   ChiTaRS; LARS2; human.
DR   GeneWiki; LARS2; -.
DR   GenomeRNAi; 23395; -.
DR   PRO; PR:Q15031; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000011376; -.
DR   CleanEx; HS_LARS2; -.
DR   ExpressionAtlas; Q15031; baseline and differential.
DR   Genevisible; Q15031; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004823; F:leucine-tRNA ligase activity; IDA:UniProtKB.
DR   GO; GO:0006429; P:leucyl-tRNA aminoacylation; IDA:HGNC.
DR   GO; GO:0032543; P:mitochondrial translation; IBA:GO_Central.
DR   GO; GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome.
DR   Gene3D; 1.10.730.10; -; 1.
DR   Gene3D; 3.40.50.620; -; 1.
DR   InterPro; IPR001412; aa-tRNA-synth_I_CS.
DR   InterPro; IPR002300; aa-tRNA-synth_Ia.
DR   InterPro; IPR002302; Leu-tRNA-ligase.
DR   InterPro; IPR013155; M/V/L/I-tRNA-synth_anticd-bd.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd.
DR   InterPro; IPR009008; Val/Leu/Ile-tRNA-synth_edit.
DR   PANTHER; PTHR43740; PTHR43740; 1.
DR   Pfam; PF08264; Anticodon_1; 1.
DR   Pfam; PF00133; tRNA-synt_1; 3.
DR   PRINTS; PR00985; TRNASYNTHLEU.
DR   SUPFAM; SSF47323; SSF47323; 1.
DR   SUPFAM; SSF50677; SSF50677; 1.
DR   TIGRFAMs; TIGR00396; leuS_bact; 1.
DR   PROSITE; PS00178; AA_TRNA_LIGASE_I; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Aminoacyl-tRNA synthetase; ATP-binding;
KW   Complete proteome; Deafness; Disease mutation; Ligase; Mitochondrion;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Protein biosynthesis; Reference proteome; Transit peptide.
FT   TRANSIT       1      ?       Mitochondrion. {ECO:0000255}.
FT   CHAIN         ?    903       Probable leucine--tRNA ligase,
FT                                mitochondrial.
FT                                /FTId=PRO_0000035806.
FT   MOTIF        92    102       "HIGH" region.
FT   MOTIF       639    643       "KMSKS" region.
FT   BINDING     642    642       ATP. {ECO:0000250}.
FT   MOD_RES      68     68       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8VDC0}.
FT   MOD_RES     236    236       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     711    711       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT     430    430       A -> V (in HLASA; decreased leucine-tRNA
FT                                ligase activity).
FT                                {ECO:0000269|PubMed:26537577}.
FT                                /FTId=VAR_076997.
FT   VARIANT     522    522       T -> N (in PRLTS4 and HLASA; reduced
FT                                activity; decreased leucine-tRNA ligase
FT                                activity; dbSNP:rs199589947).
FT                                {ECO:0000269|PubMed:23541342,
FT                                ECO:0000269|PubMed:26537577}.
FT                                /FTId=VAR_070094.
FT   VARIANT     629    629       T -> M (in PRLTS4; found in a compound
FT                                heterozygote also carrying a null
FT                                mutation; the mutant is functional in a
FT                                yeast complementaion assay but might be
FT                                insufficient as a heterozygote with a
FT                                fully non-functional allele;
FT                                dbSNP:rs398123036).
FT                                {ECO:0000269|PubMed:23541342}.
FT                                /FTId=VAR_070095.
FT   VARIANT     727    727       K -> N (in dbSNP:rs36054230).
FT                                /FTId=VAR_052638.
FT   VARIANT     831    831       E -> D (in dbSNP:rs9827689).
FT                                /FTId=VAR_052639.
SQ   SEQUENCE   903 AA;  101976 MW;  D9AC143125124F58 CRC64;
     MASVWQRLGF YASLLKRQLN GGPDVIKWER RVIPGCTRSI YSATGKWTKE YTLQTRKDVE
     KWWHQRIKEQ ASKISEADKS KPKFYVLSMF PYPSGKLHMG HVRVYTISDT IARFQKMRGM
     QVINPMGWDA FGLPAENAAV ERNLHPQSWT QSNIKHMRKQ LDRLGLCFSW DREITTCLPD
     YYKWTQYLFI KLYEAGLAYQ KEALVNWDPV DQTVLANEQV DEHGCSWRSG AKVEQKYLRQ
     WFIKTTAYAK AMQDALADLP EWYGIKGMQA HWIGDCVGCH LDFTLKVHGQ ATGEKLTAYT
     ATPEAIYGTS HVAISPSHRL LHGHSSLKEA LRMALVPGKD CLTPVMAVNM LTQQEVPVVI
     LAKADLEGSL DSKIGIPSTS SEDTILAQTL GLAYSEVIET LPDGTERLSS SAEFTGMTRQ
     DAFLALTQKA RGKRVGGDVT SDKLKDWLIS RQRYWGTPIP IVHCPVCGPT PVPLEDLPVT
     LPNIASFTGK GGPPLAMASE WVNCSCPRCK GAAKRETDTM DTFVDSAWYY FRYTDPHNPH
     SPFNTAVADY WMPVDLYIGG KEHAVMHLFY ARFFSHFCHD QKMVKHREPF HKLLAQGLIK
     GQTFRLPSGQ YLQREEVDLT GSVPVHAKTK EKLEVTWEKM SKSKHNGVDP EEVVEQYGID
     TIRLYILFAA PPEKDILWDV KTDALPGVLR WQQRLWTLTT RFIEARASGK SPQPQLLSNK
     EKAEARKLWE YKNSVISQVT THFTEDFSLN SAISQLMGLS NALSQASQSV ILHSPEFEDA
     LCALMVMAAP LAPHVTSEIW AGLALVPRKL CAHYTWDASV LLQAWPAVDP EFLQQPEVVQ
     MAVLINNKAC GKIPVPQQVA RDQDKVHEFV LQSELGVRLL QGRSIKKSFL SPRTALINFL
     VQD
//
